Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...

Health secretary Robert F. Kennedy Jr. yesterday appointed a new, smaller vaccine advisory committee at the CDC — just two ...

The FDA’s accelerated approval pathway plays a vital role, and scrapping it or reversing course on already-approved therapies ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

The benefits of drug warranties extend beyond risk management. They can also serve as market differentiators in crowded ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

In a global first for Africa, UCT is participating in a clinical trial to reprogramme genes and halt hereditary angioedema.

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

Alpha-1 is a microcosm of the rare disease world. The challenges we face, late diagnoses, inconsistent care, and unaffordable ...

Learn more about the effects US pharmaceutical tariffs could have on European companies and their strategies for overcoming ...

A combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid ...